Valuation: Cipla Limited

Market Cap 1,190B 12.47B 10.84B 10.09B 9.26B 17.49B 17.76B 119B 46.67B 592B 46.82B 45.79B 1,987B P/E 2027 *
28.7x
P/E 2028 * 23.1x
Enterprise Value 1,084B 11.36B 9.87B 9.19B 8.44B 15.93B 16.18B 108B 42.51B 540B 42.65B 41.71B 1,810B EV / Sales 2027 *
3.5x
EV / Sales 2028 * 3.05x
Free-Float
68.88%
Yield 2027 *
0.87%
Yield 2028 * 0.98%
1 day+0.46%
1 week+4.44%
1 month+0.53%
3 months+12.49%
6 months+11.27%
Current year-2.52%
1 week 1,392.8
Extreme 1392.8
1,491.2
1 month 1,366.1
Extreme 1366.1
1,491.2
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
President - 2026-05-17
Director of Finance/CFO - 2026-07-23
Director TitleAgeSince
Chairman 90 1972-07-20
Director/Board Member 72 2014-07-24
Director/Board Member 71 2021-06-29
Date Insider Type Main position Quantity % Market Cap.
8/22/24 Sell 2,000 0.0002%
8/14/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%+4.44%-5.24%+25.38% 12.47B
-0.53%+2.54%+16.63%+74.09% 50.03B
-1.81%-0.49%+51.99%+112.44% 36.6B
+1.05%+1.63%+16.19%+78.22% 11.77B
-1.33%-0.76%+30.08%+131.70% 9.04B
-2.99%-2.09%+41.02%-8.36% 7.03B
+0.51%+1.46%+12.17%+32.88% 6.79B
-.--%+0.14% - - 6.79B
+1.99%+1.91%+4.68%+183.54% 6.6B
-.--%-1.95% - - 5.73B
Average -0.26%+0.53%+20.94%+78.74% 15.28B
Weighted average by Cap. -0.60%+0.60%+25.18%+82.84%

Financials

2027 *2028 *
Net sales 310B 3.25B 2.82B 2.63B 2.41B 4.55B 4.62B 30.96B 12.15B 154B 12.19B 11.92B 517B 347B 3.64B 3.16B 2.94B 2.7B 5.1B 5.18B 34.7B 13.62B 173B 13.66B 13.36B 580B
Net income 41.35B 433M 377M 350M 322M 608M 617M 4.13B 1.62B 20.59B 1.63B 1.59B 69.03B 51.42B 539M 468M 436M 400M 756M 767M 5.14B 2.02B 25.6B 2.02B 1.98B 85.84B
Net Debt -106B -1.11B -966M -899M -825M -1.56B -1.58B -10.6B -4.16B -52.81B -4.17B -4.08B -177B -131B -1.38B -1.2B -1.11B -1.02B -1.93B -1.96B -13.13B -5.15B -65.44B -5.17B -5.06B -219B
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
26-07-31 ₹1,473.20 +0.46% 1,223,370
26-07-30 ₹1,466.40 -0.54% 833,068
26-07-29 ₹1,474.30 +2.06% 2,192,262
26-07-28 ₹1,444.60 +2.50% 1,621,735
26-07-27 ₹1,409.40 -0.09% 1,162,030
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,473.20INR
Average target price
1,512.86INR
Spread / Average Target
+2.69%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock